Cincinnati Financial Corp’s AbbVie ABBV Stock Holding History

Cincinnati Financial Corp’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$123M	Hold	566,800	–	–	2.48%	17
2025 Q4	$130M	Hold	566,800	–	–	2.53%	15
2025 Q3	$131M	Hold	566,800	–	–	2.6%	14
2025 Q2	$105M	Hold	566,800	–	–	2.23%	16
2025 Q1	$119M	Hold	566,800	–	–	2.65%	14
2024 Q4	$101M	Hold	566,800	–	–	2.21%	18
2024 Q3	$112M	Hold	566,800	–	–	2.41%	15
2024 Q2	$97.2M	Hold	566,800	–	–	2.09%	16
2024 Q1	$103M	Hold	566,800	–	–	2.27%	14
2023 Q4	$87.8M	Hold	566,800	–	–	1.93%	19
2023 Q3	$84.5M	Hold	566,800	–	–	2.04%	17
2023 Q2	$76.4M	Hold	566,800	–	–	1.75%	18
2023 Q1	$90.3M	Hold	566,800	–	–	2.19%	16
2022 Q4	$91.6M	Hold	566,800	–	–	2.31%	16
2022 Q3	$76.1M	Hold	566,800	–	–	2.09%	18
2022 Q2	$86.8M	Hold	566,800	–	–	2.21%	17
2022 Q1	$91.9M	Hold	566,800	–	–	2.04%	18
2021 Q4	$76.7M	Hold	566,800	–	–	1.61%	21
2021 Q3	$61.1M	Buy	566,800 +28,000	+5%	+$3.2M	1.5%	24
2021 Q2	$60.7M	Buy	538,800 +22,000	+4%	+$2.48M	1.48%	23
2021 Q1	$55.9M	Hold	516,800	–	–	1.45%	25
2020 Q4	$55.4M	Buy	516,800 +90,000	+21%	+$8.65M	1.5%	24
2020 Q3	$37.4M	Hold	426,800	–	–	1.14%	27
2020 Q2	$41.9M	Hold	426,800	–	–	1.41%	26
2020 Q1	$32.5M	Hold	426,800	–	–	1.3%	26
2019 Q4	$37.8M	Hold	426,800	–	–	1.23%	27
2019 Q3	$32.3M	Buy	426,800 +30,000	+8%	+$2.06M	1.15%	29
2019 Q2	$28.9M	Buy	396,800 +55,000	+16%	+$4.32M	1.06%	29
2019 Q1	$27.5M	Hold	341,800	–	–	1.11%	31
2018 Q4	$31.5M	Hold	341,800	–	–	1.41%	26
2018 Q3	$32.3M	Hold	341,800	–	–	1.26%	27
2018 Q2	$31.7M	Hold	341,800	–	–	1.35%	26
2018 Q1	$32.4M	Hold	341,800	–	–	1.41%	27
2017 Q4	$33.1M	Hold	341,800	–	–	1.45%	27
2017 Q3	$30.4M	Hold	341,800	–	–	1.38%	27
2017 Q2	$24.8M	Hold	341,800	–	–	1.17%	30
2017 Q1	$22.3M	Hold	341,800	–	–	1.08%	31
2016 Q4	$21.4M	Hold	341,800	–	–	1.17%	30
2016 Q3	$21.6M	Hold	341,800	–	–	1.2%	32
2016 Q2	$21.2M	Hold	341,800	–	–	1.19%	32
2016 Q1	$19.5M	Hold	341,800	–	–	1.15%	31
2015 Q4	$20.2M	Buy	341,800 +110,000	+47%	+$6.34M	1.28%	28
2015 Q3	$12.6M	Buy	231,800 +14,000	+6%	+$911K	0.82%	33
2015 Q2	$14.6M	Hold	217,800	–	–	0.91%	33
2015 Q1	$12.8M	Hold	217,800	–	–	0.77%	37
2014 Q4	$14.3M	Hold	217,800	–	–	0.87%	35
2014 Q3	$12.6M	Hold	217,800	–	–	0.83%	34
2014 Q2	$12.3M	Hold	217,800	–	–	0.83%	34
2014 Q1	$11.2M	Hold	217,800	–	–	0.81%	34
2013 Q4	$11.5M	Hold	217,800	–	–	0.84%	34
2013 Q3	$9.74M	Hold	217,800	–	–	0.78%	34
2013 Q2	$9M	Buy	+217,800	New	+$9.53M	0.75%	36

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Cincinnati Financial Corp's ABBV Position: Q1 2026 in Review

Cincinnati Financial Corp held its AbbVie (ABBV) position steady in Q1 2026 at 566,800 shares worth $123M. The position accounts for 2.48% of the portfolio, ranked #17.

Cincinnati Financial Corp first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $131M in Q3 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Cincinnati Financial Corp held 566,800 shares of AbbVie worth $123M as of Q1 2026.
Cincinnati Financial Corp left its AbbVie share count unchanged in Q1 2026.
AbbVie made up 2.48% of Cincinnati Financial Corp's portfolio in Q1 2026, its #17 holding.
Cincinnati Financial Corp first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
Cincinnati Financial Corp's AbbVie position peaked at $131M in Q3 2025.
4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Cincinnati Financial Corp's 13F filing for Q1 2026, filed 11 May 2026.